Yongzhang Luo

Person

Yantai City, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleolin-mediated cancer diagnostics and therapy
- Patent number 11,434,288
- Issue date Sep 6, 2022
- Protogen Ltd.
- Yongzhang Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Molecular design of recombinant protein drug
- Patent number 10,869,910
- Issue date Dec 22, 2020
- Tsinghua University
- Yongzhang Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Endostatin mutants with mutations at ATP binding sites
- Patent number 10,647,968
- Issue date May 12, 2020
- Tsinghua University
- Yongzhang Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of nucleolin as a biomarker for lymphangiogenesis in a cancer p...
- Patent number 10,054,590
- Issue date Aug 21, 2018
- Tsinghua University
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of inhibiting or treating cancer metastasis
- Patent number 9,815,906
- Issue date Nov 14, 2017
- Tsinghua University
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for enhancing the uptake of therapeutic ag...
- Patent number 9,364,493
- Issue date Jun 14, 2016
- Tsinghua University
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Application of fibrinogen-420 and its active domain
- Patent number 9,145,452
- Issue date Sep 29, 2015
- Tsinghua University
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for cancer detection
- Patent number 8,975,030
- Issue date Mar 10, 2015
- Tsinghua University
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor biomarker
- Patent number 8,389,684
- Issue date Mar 5, 2013
- Tsinghua University
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cancer using a modified endostatin protein
- Patent number 7,470,667
- Issue date Dec 30, 2008
- Medgenn (Hong Kong) Ltd
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-terminal modified recombinant human endostatin and its production
- Patent number 7,078,485
- Issue date Jul 18, 2006
- Yantai Medgenn Ltd.
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MEDICATION FOR INHIBITING DNA-PKCS
- Publication number 20240165140
- Publication date May 23, 2024
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF HUMAN SERUM ALBUMIN IN TREATMENT OF DISEASES
- Publication number 20230390364
- Publication date Dec 7, 2023
- Shenzhen Protgen Ltd.
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
YOUNG AND UNDAMAGED HUMAN SERUM ALBUMIN IMPROVES LONGEVITY OF HUMAN
- Publication number 20230265166
- Publication date Aug 24, 2023
- SHENZHEN PROTGEN LTD.
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEOLIN-MEDIATED CANCER DIAGNOSTICS AND THERAPY
- Publication number 20230174644
- Publication date Jun 8, 2023
- TSINGHUA UNIVERSITY
- Yongzhang Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESIST...
- Publication number 20220409703
- Publication date Dec 29, 2022
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MOLECULAR DESIGN OF RECOMBINANT PROTEIN DRUG
- Publication number 20210085754
- Publication date Mar 25, 2021
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MEDICATION FOR INHIBITING DNA-PKCS
- Publication number 20200237796
- Publication date Jul 30, 2020
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF
- Publication number 20180360922
- Publication date Dec 20, 2018
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MOLECULAR DESIGN OF RECOMBINANT PROTEIN DRUG
- Publication number 20180200337
- Publication date Jul 19, 2018
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR INHIBITING LYMPHANGIOGENESIS BY ADMINISTRATION OF AN INH...
- Publication number 20180094051
- Publication date Apr 5, 2018
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESIST...
- Publication number 20180015148
- Publication date Jan 18, 2018
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR BIOMARKER
- Publication number 20160178633
- Publication date Jun 23, 2016
- TSINGHUA UNIVERSITY
- Yongzhang Luo
- G01 - MEASURING TESTING
Information Patent Application
METHOD FOR CANCER DETECTION
- Publication number 20150259432
- Publication date Sep 17, 2015
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENDOSTATIN MUTANTS WITH MUTATIONS AT ATP BINDING SITES
- Publication number 20150197733
- Publication date Jul 16, 2015
- BEIJING PROTGEN LTD.
- Yongzhang Luo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AG...
- Publication number 20140335152
- Publication date Nov 13, 2014
- TSINGHUA UNIVERSITY
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENDOSTATIN MUTANTS WITH MUTATIONS AT ATP BINDING SITES
- Publication number 20140308263
- Publication date Oct 16, 2014
- BEIJING PROTGEN LTD.
- Yongzhang Luo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD AND MEDICAMENT FOR INHIBITING LYMPHANGIOGENESIS
- Publication number 20140193424
- Publication date Jul 10, 2014
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AG...
- Publication number 20140147492
- Publication date May 29, 2014
- TSINGHUA UNIVERSITY
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL APPLICATION OF FIBRINOGEN-420 AND ITS ACTIVE DOMAIN
- Publication number 20140087441
- Publication date Mar 27, 2014
- TSINGHUA UNIVERSITY
- YONGZHANG LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATE ANGIOSTATION OR ITS FRAGMENT, THE METHOD OF PRODUCING THE...
- Publication number 20140056966
- Publication date Feb 27, 2014
- Protgen Ltd.
- Yongzhang Luo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF NUCLEOLIN AS A BIOMARKER FOR LYMPHANGIOGENESIS IN A CANCER P...
- Publication number 20140037655
- Publication date Feb 6, 2014
- Protgen Ltd.
- Yongzhang Luo
- G01 - MEASURING TESTING
Information Patent Application
METHOD FOR CANCER DETECTION
- Publication number 20130243757
- Publication date Sep 19, 2013
- Protgen Ltd.
- Yongzhang LUO
- G01 - MEASURING TESTING
Information Patent Application
USE OF NUCLEOLIN AS A BIOMARKER FOR LYMPHANGIOGENESIS IN CANCER PRO...
- Publication number 20130023479
- Publication date Jan 24, 2013
- Protgen Ltd.
- Yongzhang Luo
- G01 - MEASURING TESTING
Information Patent Application
NOVEL APPLICATION OF FIBRINOGEN-420 AND ITS ACTIVE DOMAIN
- Publication number 20120165510
- Publication date Jun 28, 2012
- TSINGHUA UNIVERSITY
- Luo Yongzhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Tumor Biomarket
- Publication number 20120064078
- Publication date Mar 15, 2012
- Protgen Ltd.
- Yongzhang LUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUND FOR TREATMENT OF TUMOR
- Publication number 20100303893
- Publication date Dec 2, 2010
- Yongzhang Luo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF
- Publication number 20100285103
- Publication date Nov 11, 2010
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR P...
- Publication number 20100184661
- Publication date Jul 22, 2010
- Protgen Ltd.
- Yongzhang Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleolin-Mediated Cancer Diagnostics and Therapy
- Publication number 20090191224
- Publication date Jul 30, 2009
- TSINGHUA UNIVERSITY
- Yongzhang Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nucleolin-mediated cancer diagnostics and therapy
- Publication number 20060258605
- Publication date Nov 16, 2006
- Yongzhang Luo
- C07 - ORGANIC CHEMISTRY

Yongzhang Luo

Person

Patents Grantslast 30 patents

Nucleolin-mediated cancer diagnostics and therapy

Molecular design of recombinant protein drug

Endostatin mutants with mutations at ATP binding sites

Use of nucleolin as a biomarker for lymphangiogenesis in a cancer p...

Method of inhibiting or treating cancer metastasis

Methods and compositions for enhancing the uptake of therapeutic ag...

Application of fibrinogen-420 and its active domain

Method for cancer detection

Tumor biomarker

Methods of treating cancer using a modified endostatin protein

N-terminal modified recombinant human endostatin and its production

Patents Applicationslast 30 patents

MEDICATION FOR INHIBITING DNA-PKCS

USE OF HUMAN SERUM ALBUMIN IN TREATMENT OF DISEASES

YOUNG AND UNDAMAGED HUMAN SERUM ALBUMIN IMPROVES LONGEVITY OF HUMAN

NUCLEOLIN-MEDIATED CANCER DIAGNOSTICS AND THERAPY

DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESIST...

MOLECULAR DESIGN OF RECOMBINANT PROTEIN DRUG

MEDICATION FOR INHIBITING DNA-PKCS

MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF

MOLECULAR DESIGN OF RECOMBINANT PROTEIN DRUG

METHOD FOR INHIBITING LYMPHANGIOGENESIS BY ADMINISTRATION OF AN INH...

DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESIST...

TUMOR BIOMARKER

METHOD FOR CANCER DETECTION

ENDOSTATIN MUTANTS WITH MUTATIONS AT ATP BINDING SITES

METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AG...

ENDOSTATIN MUTANTS WITH MUTATIONS AT ATP BINDING SITES

METHOD AND MEDICAMENT FOR INHIBITING LYMPHANGIOGENESIS

METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AG...

NOVEL APPLICATION OF FIBRINOGEN-420 AND ITS ACTIVE DOMAIN

CONJUGATE ANGIOSTATION OR ITS FRAGMENT, THE METHOD OF PRODUCING THE...

USE OF NUCLEOLIN AS A BIOMARKER FOR LYMPHANGIOGENESIS IN A CANCER P...

METHOD FOR CANCER DETECTION

USE OF NUCLEOLIN AS A BIOMARKER FOR LYMPHANGIOGENESIS IN CANCER PRO...

NOVEL APPLICATION OF FIBRINOGEN-420 AND ITS ACTIVE DOMAIN

Novel Tumor Biomarket

NOVEL COMPOUND FOR TREATMENT OF TUMOR

MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF

CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR P...

Nucleolin-Mediated Cancer Diagnostics and Therapy

Nucleolin-mediated cancer diagnostics and therapy